2nd Quarter - Amendment

ALSTON & BIRD LLP for CELGENE CORPORATION

Firm
Client
Income
$80,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 10, 2014 $70,000 Replaced
2nd Quarter - Amendment (this page) Jul 22, 2014 $80,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to prescription drugs in health care bills; orphan drug and rare disease bills; Family Cord Blood Banking Act; Cancer Drug Coverage Parity Act of 2013 (HR 1801); Patients Access to Treatment Act of 2013 (HR 460); MODDERN Cures Act of 2013 (H.R.3116); Veterans access legislation (H.R. 3230/H.R.4810).

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1801 (113th), H.R. 460 (113th), H.R. 3230 (113th), H.R. 3116 (113th), H.R. 4810 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.